Geron Corporation’s Post

🚀 Introducing Our New Series: Proven in Action 🚀 We're excited to kick off our new series. Each week, we'll share validation data and insights from millions of experiments showcasing the exceptional performance of our cell culture media. This week, we're highlighting #A549 and #Calu3 cells, two key players in #lungcancer research. Discover how our media supports their growth and viability, backed by robust validation. 🔗 https://lnkd.in/eB84v7ti #CellCulture #CancerResearch #A549Cells #Calu3Cells #ProvenInAction

Together, we make science exponentially better! Through collaborative efforts, we strive to push the boundaries of scientific knowledge, driving progress and empowering you to achieve your goals. Let's innovate and inspire the future, one breakthrough at a time! 🚀🔬 #thermofisheremp 📩 Need help? Send me a mail to [email protected] with the topic 'LinkedIn'

At Fortrea, we lead with science. Here is a piece of thought leadership on bladder cancer. Immune checkpoint inhibitors (ICI) have become an important therapeutic approach for bladder cancer. This article describes a recent study on Y chromosome loss (LOY) and how tumors with LOY may be susceptible to treatment with ICIs.

To learn more about Gamzook'aamin aakoziwin (Bruce Power - SON partnership): https://lnkd.in/eQmEuU-i

#CuttingEdgeResearch #HealthcareInnovation #UnlockingMysteries Science is making history! This video delves into recent advancements in understanding life's origin & a potential game-changer in cancer treatment. Watch & discuss: how will these discoveries impact the future of science & humanity? #ScientificProgress #CollaborationIsKey #ThinkBig https://lnkd.in/g9EWFAnp

Why is CyTOF® the right way for deep profiling?   In the video linked below, you can learn more about how Taylor Witte, Senior Associate Scientist at 2seventy bio™, uses CyTOF® to deeply characterize all cell phenotypes, instead of having to focus on just one at a time, thus avoiding wasting precious sample material.   Effective and reproducible, every time.   Contact your local AH diagnostics Product Specialist to explore how you can benefit from CyTOF® technology in your research.   #CARTcells #ImmunoTherapy #CancerResearch #LifeScience #YourScienceOurFocus

Alleles, hybrids, genotypes, homozygosity, heterozygosity explained An allele is one of two, or more, forms of a given gene variant. For example, the ABO blood grouping is controlled by the ABO gene, which has six common alleles. Nearly every living human's phenotype for the ABO gene is some combination of just these six alleles. Youtube video: https://lnkd.in/dpz4F9T5 \#nikolays_genetics_lessons

Bentonite Clay is an inexpensive, easily-obtained substance that has shown firm evidence of killing human cancer cells and of detoxifying mammals from heavy metals. People have ingested clay and used it topically, for millennia. Let's explore. Become a content creator, try out StreamYard or enhance your existing broadcasts today! (We love it! And it's American owned, top to bottom!). Click here to give it a try: Want to create live streams like this? Check out StreamYard: https://lnkd.in/eUKVDJe7

📣For ESMO members: Breaking Science in #BreastCancer. Guillermo Villacampa presents the HER2DX assay and its impact on survival outcomes. 👉 Discover this video and more in the series on OncologyPRO now. 🔗 https://ow.ly/bOMn50SmxWG #ESMOBreast24

This. Is. Amazing!!!! I can’t even tell you how much of a swell of HOPE I feel watching this video and knowing that, through #CureAP4 and #JackCorner’s collaborative partnership with Unravel Bio, some very strong predictions have been identified that might offer real, meaningful therapeutics to all FOUR of the AP-4-Associated #HereditarySpasticParaplegia (#AP4HSP subtypes (#SPG47, #SPG50, #SPG51, #SPG52). One drug they found “ “A particular drug was very effective in computational tests, ranking second out of about 1,000 compounds for its potential to help restore health, and ranked 93% when scored across all four patient groups.” According to the team Unravel Biosciences “This is a very strong hit even when groups are analyzed separately.” And the knock-out disease tadpole model research for safety and efficacy testing of the first round predicted compounds MAY BE COMPLETED BEND OF THIS NOVEMBER! We are thisclose to at least an answer. A go/no-go to move onto An AP4B1 KO mouse models and then, if all good, TREATING OUR AP-4 AFFECTED CHILDREN!!! Richard Novak and Frederic Vigneault and the entire team Unravel Biosciences - you are doing the work of heroes!